ARCHIVES

DCT Board Approves Recompetition Of Drug Development Contracts

This article is from The Cancer Letter archive.

Vol. 19 No. 26 | June 25, 1993

Download PDF Visit The Full Archive

Related Articles

Abstract Of Papers From ASTR Meeting

November 5, 1976

Cyramza-Docetaxel Combination Extends OS In Second-Line NSCLC

June 27, 2014

NIAID, Vaccine Center Begin Phase I Trial Of AIDS Vaccine.

October 12, 2001

Two Drugs Slow Progress Of Metastatic Prostate Cancer

June 29, 2001

Breast, Ovarian Cancers Detected Early In Women At High Hereditary Risk

March 29, 2002

NCI Programs: Institute Partners With Two Groups On Psychosocial Issues

May 16, 1997